Hurwitz HI - Search Results

1

Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook.

Garcia J, Hurwitz HI, Sandler AB, Miles D, Coleman RL, Deurloo R, Chinot OL. Garcia J, et al. Among authors: hurwitz hi. Cancer Treat Rev. 2020 Jun;86:102017. doi: 10.1016/j.ctrv.2020.102017. Epub 2020 Mar 26. Cancer Treat Rev. 2020. PMID: 32335505 Free article. Review.

2

Targeted therapy of colorectal cancer: clinical experience with bevacizumab.

Fernando NH, Hurwitz HI. Fernando NH, et al. Among authors: hurwitz hi. Oncologist. 2004;9 Suppl 1:11-8. doi: 10.1634/theoncologist.9-suppl_1-11. Oncologist. 2004. PMID: 15178811 Free article. Review.

3

Association of k-ras, b-raf, and p53 status with the treatment effect of bevacizumab.

Ince WL, Jubb AM, Holden SN, Holmgren EB, Tobin P, Sridhar M, Hurwitz HI, Kabbinavar F, Novotny WF, Hillan KJ, Koeppen H. Ince WL, et al. Among authors: hurwitz hi. J Natl Cancer Inst. 2005 Jul 6;97(13):981-9. doi: 10.1093/jnci/dji174. J Natl Cancer Inst. 2005. PMID: 15998951

4

Disease course patterns after discontinuation of bevacizumab: pooled analysis of randomized phase III trials.

Miles D, Harbeck N, Escudier B, Hurwitz H, Saltz L, Van Cutsem E, Cassidy J, Mueller B, Sirzén F. Miles D, et al. J Clin Oncol. 2011 Jan 1;29(1):83-8. doi: 10.1200/JCO.2010.30.2794. Epub 2010 Nov 22. J Clin Oncol. 2011. PMID: 21098326

5

Understanding the mechanisms of action of antiangiogenic agents in metastatic colorectal cancer: a clinician's perspective.

Clarke JM, Hurwitz HI, Rangwala F. Clarke JM, et al. Among authors: hurwitz hi. Cancer Treat Rev. 2014 Oct;40(9):1065-72. doi: 10.1016/j.ctrv.2014.07.001. Epub 2014 Jul 11. Cancer Treat Rev. 2014. PMID: 25047778 Review.

6

Combinations of Bevacizumab With Cancer Immunotherapy.

Chen DS, Hurwitz H. Chen DS, et al. Cancer J. 2018 Jul/Aug;24(4):193-204. doi: 10.1097/PPO.0000000000000327. Cancer J. 2018. PMID: 30119083 Review.

7

Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancer.

Loupakis F, Hurwitz HI, Saltz L, Arnold D, Grothey A, Nguyen QL, Osborne S, Talbot J, Srock S, Lenz HJ. Loupakis F, et al. Among authors: hurwitz hi. Br J Cancer. 2018 Dec;119(12):1451-1455. doi: 10.1038/s41416-018-0304-6. Epub 2018 Nov 29. Br J Cancer. 2018. PMID: 30487637 Free PMC article.

8

Targeting vascular endothelial growth factor and angiogenesis for the treatment of colorectal cancer.

Collins TS, Hurwitz HI. Collins TS, et al. Among authors: hurwitz hi. Semin Oncol. 2005 Feb;32(1):61-8. doi: 10.1053/j.seminoncol.2004.09.026. Semin Oncol. 2005. PMID: 15726507 Review.

9

Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab.

Scappaticci FA, Fehrenbacher L, Cartwright T, Hainsworth JD, Heim W, Berlin J, Kabbinavar F, Novotny W, Sarkar S, Hurwitz H. Scappaticci FA, et al. J Surg Oncol. 2005 Sep 1;91(3):173-80. doi: 10.1002/jso.20301. J Surg Oncol. 2005. PMID: 16118771

10

Long-term treatment with bevacizumab for patients with metastatic colorectal cancer: case report.

Hurwitz HI, Honeycutt W, Haley S, Favaro J. Hurwitz HI, et al. Clin Colorectal Cancer. 2006 May;6(1):66-9. doi: 10.3816/CCC.2006.n.023. Clin Colorectal Cancer. 2006. PMID: 16796794

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

212 results

Search Page

Filters